OpGen Reports Fourth Quarter and Full Year 2022 Financial Re

Total revenue for 2022 was approximately $2.6 millionBalance sheet strengthened by recently closed public offering with gross proceeds of $7.5 millionConference call to be held March... | March 29, 2023

Related Keywords

Vienna , Wien , Austria , Ukraine , Russia , China , Beijing , Chinese , Curetis Gmb , Oliver Schacht , Albert Weber , Gene Panel , International Number , Foundation For Innovative New Diagnostics , Nasdaq , European Investment Bank , Securities Exchange , Opgen Investor Press Contact , Technology Platform , Opgen Inc , Exchange Commission , Edison Group , Full Year , Chief Financial Officer , Beijing Clear Biotech , Ares Genetics , Innovative New Diagnostics , Dial In Number , United Statesa , Curetis Gmbh , Ares Genetics Gmbh , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Nasdaq Capital Market , Gen Investor , Press Contact , Months Ended December , Ended December , Opgen , Nc Stock Exchange , News , Information , Press Release , Total , Revenue , Or , 022 , Gas , Illionbalance , Sheet , Strengthened , Y , Ecently , Closed , Public , Offering , Ith , Cross , Proceeds , F , Illionconference , Wall , O , E Opgn Us68373l4068 ,